Timing of troughs Troughs should be obtained at steady state: approximately prior to the fifth dose IIB Optimal trough concentrations Should be >10 mg/l at a minimum to avoid development of ...

Staphylococcus aureus has the potential to develop durable vancomycin resistance, according to a study published August 28, 2024, in the open-access journal PLOS Pathogens by Samuel Blechman and Erik ...

In an analysis of more than 8,000 episodes of Staphylococcus aureus bloodstream infections, there were no significant differences in the risk of death when comparing patients exhibiting less ...

New findings published in Clinical Infectious Diseases indicate that increased vancomycin minimum inhibitory concentration was associated with a higher mortality rate in patients with ...

Clinical isolates of Staphylococcus aureus displaying intermediate resistance to vancomycin (VISA) have been identified. The objective of our study was to identify VISA colonization among patients ...

Infections with antibiotic-resistant bacteria, including methicillin-resistant Staphylococcus aureus (MRSA), vancomycin-resistant Enterococcus and Clostridium difficile, are usually considered hazards ...

Linezolid and vancomycin are the only drugs recommended by the ATS/IDSA for treatment of MRSA nosocomial pneumonia, quinupristin/dalfopristin and daptomycin should ...

Staphylococcus aureus bacteremia and endocarditis are serious infections that demand prompt clinical attention to ensure good outcomes. Of foremost importance is identifying and managing the source of ...

Staphylococcus aureus causes a variety of manifestations and diseases. The treatment of choice for S. aureus infection is penicillin. In most countries, S. aureus strains have developed a resistance ...